Department of Ophthalmology, General University Hospital of Elche, Elche, Alicante, Spain.
Department of Ophthalmology; Department of Statistics, General University Hospital of Elche, Elche, Alicante, Spain.
Indian J Ophthalmol. 2022 Sep;70(9):3213-3221. doi: 10.4103/ijo.IJO_880_22.
Iris-fixated intraocular lens (IOL) is considered a safe and effective option for the correction of aphakia in patients with insufficient capsular support. This systematic review aims to summarize the existing evidence about the Artisan/Verisyse IOLs and to assess the influence of the IOL position on the postoperative outcomes. Three different databases were used for this systematic review and metaanalysis (PubMED, Scopus, and Embase). We searched for case series or clinical trials comparing the prepupillary versus retropupillary Artisan/Verisyse implantation. The statistical analysis was performed with the programming language R (version 3.6.1 2019-07-05). The number of articles included in the meta-analysis was six, with 506 eyes included in total. We found no significant differences in postoperative corrected distance visual acuity (CDVA) (0.309 [0.089-0.528] vs. 0.32 [0.2-0.44]), spherical equivalent (SE) (0.0153 D [-0.362 to 0.393] vs. -0.329 D [-0.62 to - 0.038]), and central corneal cell density (CECD) (1669.85 cells [1605.949-2150.937] vs. 1635.99 cells [1413.64-1858.363]) between the prepupillary and the retropupillary implantation, respectively. There were no significant differences in the rates of cystoid macular edema (CME; 7.70% vs. 9.8%), pupil deformation (4.5% vs. 5.4% retropupillary), or IOL luxation (2.3% and 2.2%). We found little influence of the IOL position in the postoperative analyzed outcomes. Thus, the implant position should be based on the surgeon's technical experience. Double-blind randomized prospective studies would improve the available evidence on the best implant position for the Artisan/Verisyse IOL.
虹膜固定型人工晶状体 (IOL) 被认为是一种安全有效的方法,可用于矫正因囊袋支持不足导致的无晶状体眼。本系统评价旨在总结现有关于 Artisan/Verisyse IOL 的证据,并评估 IOL 位置对术后结果的影响。本系统评价和荟萃分析使用了三个不同的数据库 (PubMED、Scopus 和 Embase)。我们检索了比较前房瞳孔内与后房瞳孔内植入 Artisan/Verisyse 的病例系列或临床试验。统计分析使用编程语言 R(版本 3.6.1,2019-07-05)进行。荟萃分析共纳入 6 项研究,共纳入 506 只眼。我们发现术后矫正远视力 (CDVA) (0.309 [0.089-0.528] vs. 0.32 [0.2-0.44])、等效球镜 (SE) (0.0153 D [-0.362 至 0.393] vs. -0.329 D [-0.62 至 -0.038]) 和中央角膜细胞密度 (CECD) (1669.85 个细胞 [1605.949-2150.937] vs. 1635.99 个细胞 [1413.64-1858.363]) 之间无显著差异。前房瞳孔内与后房瞳孔内植入的患者,发生囊样黄斑水肿 (CME) 的比例 (7.70% vs. 9.8%)、瞳孔变形 (4.5% vs. 5.4% 后房瞳孔内) 和 IOL 脱位率 (2.3% 和 2.2%) 之间无显著差异。我们发现 IOL 位置对术后分析结果的影响很小。因此,植入位置应根据外科医生的技术经验来决定。双盲随机前瞻性研究将提高关于 Artisan/Verisyse IOL 最佳植入位置的现有证据。